Published in AIDS Behav on June 01, 2015
Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users. Endocr Connect (2015) 0.75
The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy. HIV Med (2016) 0.75
Rates and risk factors associated with the progression of HIV to AIDS among HIV patients from Zhejiang, China between 2008 and 2012. AIDS Res Ther (2015) 0.75
HIV, Tat and dopaminergic transmission. Neurobiol Dis (2017) 0.75
Behavioral Interventions Targeting Alcohol Use Among People Living with HIV/AIDS: A Systematic Review and Meta-Analysis. AIDS Behav (2017) 0.75
A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care (1996) 70.87
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet (2002) 16.56
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet (2008) 11.44
Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr (2001) 3.67
Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr (2007) 3.24
Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol (2006) 2.81
Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS (2008) 2.28
Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J Acquir Immune Defic Syndr (2009) 2.17
Breaking worse: the emergence of krokodil and excessive injuries among people who inject drugs in Eurasia. Int J Drug Policy (2013) 1.92
Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS (2001) 1.88
Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses (2010) 1.85
Opioids, opioid receptors, and the immune response. Drug Alcohol Depend (2001) 1.72
The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clin Infect Dis (2005) 1.62
Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS (1990) 1.61
Differences in HIV disease progression by injecting drug use in HIV-infected persons in care. J Acquir Immune Defic Syndr (2004) 1.59
Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use. J Acquir Immune Defic Syndr (2003) 1.58
Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category. AIDS (2003) 1.55
Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia. AIDS (2006) 1.48
Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative. Ann Oncol (2010) 1.48
Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J Neuroimmunol (1998) 1.46
Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J Neuroimmune Pharmacol (2011) 1.43
Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther (2005) 1.40
Drugs of abuse, immune modulation, and AIDS. J Neuroimmune Pharmacol (2006) 1.37
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival. J Acquir Immune Defic Syndr (1999) 1.35
The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use. Addiction (2005) 1.32
Illicit drug use and HIV treatment outcomes in a US cohort. AIDS (2008) 1.24
The onset of HIV infection in the Leningrad region of Russia: a focus on drug and alcohol dependence. HIV Med (2004) 1.24
Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. J Virol (2004) 1.23
Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women. J Acquir Immune Defic Syndr (2004) 1.22
Co-morbidity of infectious and addictive diseases in St. Petersburg and the Leningrad Region, Russia. Eur Addict Res (2006) 1.22
Opioid-induced immunosuppression. Curr Opin Support Palliat Care (2008) 1.19
Illicit drugs, alcohol, and addiction in human immunodeficiency virus. Panminerva Med (2007) 1.15
Morphine enhances HIV infection of neonatal macrophages. Pediatr Res (2003) 1.13
Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts. PLoS One (2011) 1.10
The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users. AIDS (1997) 1.04
Cannabinoid neuroimmune modulation of SIV disease. J Neuroimmune Pharmacol (2011) 1.04
Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy. J Subst Abuse Treat (2011) 1.03
Multiple ways that drug abuse might influence AIDS progression: clues from a monkey model. J Neuroimmunol (2004) 1.02
Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study. AIDS (1999) 1.01
HIV-1 gp120 primes lymphocytes for opioid-induced, beta-arrestin 2-dependent apoptosis. Biochim Biophys Acta (2009) 1.00
Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J Pharmacol Exp Ther (1998) 1.00
Effects of opioid tolerance and withdrawal on the immune system. J Neuroimmune Pharmacol (2006) 1.00
Probable deceleration of progression of Simian AIDS affected by opiate dependency: studies with a rhesus macaque/SIVsmm9 model. J Acquir Immune Defic Syndr (2009) 1.00
Opioids and the progression of simian AIDS. Front Biosci (2005) 0.99
Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users. Drug Alcohol Depend (2012) 0.93
HERMITAGE--a randomized controlled trial to reduce sexually transmitted infections and HIV risk behaviors among HIV-infected Russian drinkers. Addiction (2014) 0.87
Morphine withdrawal dramatically reduces lymphocytes in morphine-dependent macaques. J Neuroimmune Pharmacol (2006) 0.85
Is cannabis use associated with HIV drug and sex risk behaviors among Russian HIV-infected risky drinkers? Drug Alcohol Depend (2013) 0.85
Pain is associated with heroin use over time in HIV-infected Russian drinkers. Addiction (2013) 0.83
Non-analgesic effects of opioids: mechanisms and potential clinical relevance of opioid-induced immunodepression. Curr Pharm Des (2012) 0.82
The influence of depressive symptoms on alcohol use among HIV-infected Russian drinkers. Drug Alcohol Depend (2013) 0.76
Brief intervention for medical inpatients with unhealthy alcohol use: a randomized, controlled trial. Ann Intern Med (2007) 4.73
Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr (2007) 3.24
Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health (2009) 2.99
Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med (2004) 2.72
Prevention of fatal opioid overdose. JAMA (2012) 2.53
Chronic care management for dependence on alcohol and other drugs: the AHEAD randomized trial. JAMA (2013) 2.36
Association between alcoholism and gamma-amino butyric acid alpha2 receptor subtype in a Russian population. Alcohol Clin Exp Res (2005) 2.35
PTSD in urban primary care: high prevalence and low physician recognition. J Gen Intern Med (2007) 2.22
Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep (2011) 2.17
Town-level characteristics and smoking policy adoption in Massachusetts: are local restaurant smoking regulations fostering disparities in health protection? Am J Public Health (2004) 2.14
Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. J Gen Intern Med (2008) 1.98
Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet (2006) 1.93
Screening and brief intervention for unhealthy drug use in primary care settings: randomized clinical trials are needed. J Addict Med (2010) 1.93
Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction (2004) 1.88
Physician education in addiction medicine. JAMA (2013) 1.87
Treating homeless opioid dependent patients with buprenorphine in an office-based setting. J Gen Intern Med (2007) 1.84
Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial. Am J Psychiatry (2012) 1.67
Alcohol and HIV disease progression: weighing the evidence. Curr HIV/AIDS Rep (2010) 1.64
Alcohol use and sex risk behaviors among HIV-infected female sex workers (FSWs) and HIV-infected male clients of FSWs in India. AIDS Behav (2010) 1.62
Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction (2007) 1.62
Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med (2006) 1.56
Addressing alcohol problems in primary care: a cluster randomized, controlled trial of a systems intervention. The screening and intervention in primary care (SIP) study. Ann Intern Med (2003) 1.54
Methadone dose, take home status, and hospital admission among methadone maintenance patients. J Addict Med (2012) 1.53
Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience. Arch Intern Med (2011) 1.53
No detectable association between frequency of marijuana use and health or healthcare utilization among primary care patients who screen positive for drug use. J Gen Intern Med (2013) 1.49
Knowledge, attitudes, and practices of US practitioners who provide pre-travel advice. J Travel Med (2014) 1.48
Burden of medical illness in drug- and alcohol-dependent persons without primary care. Am J Addict (2004) 1.46
The use of the mini-mental state examination in recruitment for substance abuse research studies. Drug Alcohol Depend (2005) 1.45
Professional satisfaction experienced when caring for substance-abusing patients: faculty and resident physician perspectives. J Gen Intern Med (2002) 1.45
Do brief measures of readiness to change predict alcohol consumption and consequences in primary care patients with unhealthy alcohol use? Alcohol Clin Exp Res (2007) 1.44
Sex trafficking and initiation-related violence, alcohol use, and HIV risk among HIV-infected female sex workers in Mumbai, India. J Infect Dis (2011) 1.43
A randomized controlled trial of an automated exercise coach for older adults. J Am Geriatr Soc (2013) 1.42
Health literacy, antiretroviral adherence, and HIV-RNA suppression: a longitudinal perspective. J Gen Intern Med (2006) 1.41
Primary medical care and reductions in addiction severity: a prospective cohort study. Addiction (2005) 1.40
Local restaurant smoking regulations and the adolescent smoking initiation process: results of a multilevel contextual analysis among Massachusetts youth. Arch Pediatr Adolesc Med (2008) 1.40
The severity of unhealthy alcohol use in hospitalized medical patients. The spectrum is narrow. J Gen Intern Med (2006) 1.38
Nondestructive characterization of nanoscale layered samples. Anal Bioanal Chem (2008) 1.38
Household smoking bans and adolescent antismoking attitudes and smoking initiation: findings from a longitudinal study of a Massachusetts youth cohort. Am J Public Health (2008) 1.36
Alcohol use and HIV risk behaviors among HIV-infected hospitalized patients in St. Petersburg, Russia. Drug Alcohol Depend (2005) 1.36
The case for chronic disease management for addiction. J Addict Med (2008) 1.36
Homeless chronicity and health-related quality of life trajectories among adults with addictions. Med Care (2005) 1.34
Inconsistent condom use among HIV-infected patients with alcohol problems. Drug Alcohol Depend (2004) 1.34
Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats. Neuropharmacology (2005) 1.34
The associations of binge alcohol use with HIV/STI risk and diagnosis among heterosexual African American men. Drug Alcohol Depend (2008) 1.33
Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects. Hypertension (2005) 1.33
Low bone density in patients receiving methadone maintenance treatment. Drug Alcohol Depend (2006) 1.32
Associations between alcohol, heroin, and cocaine use and high risk sexual behaviors among detoxification patients. Am J Drug Alcohol Abuse (2007) 1.31
Associations between vitamin K biochemical measures and bone mineral density in men and women. J Clin Endocrinol Metab (2004) 1.29
Episodic homelessness and health care utilization in a prospective cohort of HIV-infected persons with alcohol problems. BMC Health Serv Res (2006) 1.28
Slowing the revolving door: stabilization programs reduce homeless persons' substance use after detoxification. J Subst Abuse Treat (2003) 1.28
The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals. AIDS (2007) 1.26
The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr (2010) 1.25
Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems. AIDS (2008) 1.25
Effect of smoking regulations in local restaurants on smokers' anti-smoking attitudes and quitting behaviours. Tob Control (2007) 1.23
Impact of health literacy on depressive symptoms and mental health-related: quality of life among adults with addiction. J Gen Intern Med (2006) 1.21
The relationship between sexual and physical abuse and substance abuse consequences. J Subst Abuse Treat (2002) 1.20
Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. J Pain (2010) 1.19
A transitional opioid program to engage hospitalized drug users. J Gen Intern Med (2010) 1.19
Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence. Arch Gen Psychiatry (2012) 1.18
Effect of local restaurant smoking regulations on environmental tobacco smoke exposure among youths. Am J Public Health (2004) 1.18
Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts. Am J Public Health (2014) 1.17
Effects of restaurant and bar smoking regulations on exposure to environmental tobacco smoke among Massachusetts adults. Am J Public Health (2004) 1.17
Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available. Curr Psychiatry Rep (2010) 1.16
Smoking in Boston bars before and after a 100% smoke-free regulation: an assessment of early compliance. J Public Health Manag Pract (2005) 1.16
Intoxication before intercourse and risky sexual behavior in male veterans with and without human immunodeficiency virus infection. Med Care (2006) 1.13
Gender-based disparities in infant and child mortality based on maternal exposure to spousal violence: the heavy burden borne by Indian girls. Arch Pediatr Adolesc Med (2011) 1.12
Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM). Pain (2010) 1.11
The impact of alcohol use on depressive symptoms in human immunodeficiency virus-infected patients. Addiction (2008) 1.11
Improving emergency medicine residents' approach to patients with alcohol problems: a controlled educational trial. Ann Emerg Med (2002) 1.10
Some medical inpatients with unhealthy alcohol use may benefit from brief intervention. J Stud Alcohol Drugs (2009) 1.09
Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems. Alcohol Clin Exp Res (2006) 1.09
Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Drug Alcohol Depend (2007) 1.08
Alcohol use in pregnant and nonpregnant Russian women. Alcohol Clin Exp Res (2007) 1.08
Substance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems. J Subst Abuse Treat (2005) 1.07
Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. BMC Public Health (2014) 1.07
Need and non-need factors associated with addiction treatment utilization in a cohort of homeless and housed urban poor. Med Care (2006) 1.06
Alcohol and coronary heart disease: the answer awaits a randomized controlled trial. Circulation (2005) 1.06